scholarly journals Catheter ablations of supraventricular tachycardias

2012 ◽  
Vol 113 (04) ◽  
pp. 237-239
Author(s):  
S. Misikova ◽  
B. Stancak ◽  
A. Sudzinova
Keyword(s):  
Supraventricular Tachycardias

scholarly journals Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Guglielmo Capponi ◽  
Gilda Belli ◽  
Mattia Giovannini ◽  
Giulia Remaschi ◽  
Alice Brambilla ◽  
...  
Keyword(s):  
Sinus Rhythm ◽  
Beta Blocker ◽  
Pharmacological Treatment ◽  
Beta Blockers ◽  
Combined Treatment ◽  
First Year ◽  
Single Centre ◽  
International Consensus ◽  
First Year Of Life ◽  
Supraventricular Tachycardias

Abstract Background Supraventricular tachycardias (SVTs) are common in the first year of life and may be life-threatening. Acute cardioversion is usually effective, with both pharmacological and non-pharmacological procedures. However, as yet no international consensus exists concerning the best drug required for a stable conversion to sinus rhythm (maintenance treatment). Our study intends to describe the experience of a single centre with maintenance drug treatment of both re-entry and automatic SVTs in the first year of life. Methods From March 1995 to April 2019, 55 patients under one year of age with SVT were observed in our Centre. The SVTs were divided into two groups: 45 re-entry and 10 automatic tachycardias. As regards maintenance therapy, in re-entry tachycardias, we chose to start with oral flecainide and in case of relapses switched to combined treatment with beta-blockers or digoxin. In automatic tachycardias we first administered a beta-blocker, later combined with flecainide or amiodarone when ineffective. Results The patients’ median follow-up time was 35 months. In re-entry tachycardias, flecainide was effective as monotherapy in 23/45 patients (51.1%) and in 20/45 patients (44.4%) in combination with nadolol, sotalol or digoxin (overall 95.5%). In automatic tachycardias, a beta-blocker alone was effective in 3/10 patients (30.0%), however, the best results were obtained when combined with flecainide: overall 9/10 (90%). Conclusions In this retrospective study on pharmacological treatment of SVTs under 1 year of age the combination of flecainide and beta-blockers was highly effective in long-term maintenance of sinus rhythm in both re-entry and automatic tachycardias.

Comparison of Transesophageal and Intracardiac Electrophysiologic Studies for the Diagnosis of Childhood Supraventricular Tachycardias

2015 ◽  
Vol 36 (7) ◽  
pp. 1429-1435 ◽  
Author(s):  
Hayrettin Hakan Aykan ◽  
Sema Özer ◽  
Tevfik Karagöz ◽  
Alper Akın ◽  
Mustafa Gülgün ◽  
...  
Keyword(s):  
Supraventricular Tachycardias ◽  
Electrophysiologic Studies

SUPRAVENTRICULAR TACHYCARDIA WOLFF-PARKINSON-WHITE SYNDROME IN CHILDREN OF THE REPUBLIC OF BELARUS: AGE AND SEX CHARACTERISTICS, IDENTIFICATION, ELECTROPHYSIOLOGICAL STRUCTURE

2021 ◽  
pp. 110-113
Author(s):  
Strogiy V.V. ◽  
◽  
Zasim E.V. ◽  
Drozdovsky K.V. ◽  
Kadochkin V.O. ◽  
...  
Keyword(s):  
Neonatal Period ◽  
Electrophysiological Study ◽  
Conduction System ◽  
Sex Characteristics ◽  
First Year ◽  
Depth Study ◽  
The Republic ◽  
First Year Of Life ◽  
Supraventricular Tachycardias ◽  
Wolff Parkinson White Syndrome

The goal is to establish the frequency of supraventricular tachycardias in children of the Republic of Belarus, to determine the structure and characteristics of these rhythm disturbances. An in-depth study of the properties of the conduction system of the heart was carried out by performing in the course of the esophageal electrophysiological study 108 children. A more rare detection of SVT in children in the neonatal period, in the first year of life and maximum detection at the age of 17 years, a comparatively rare finding (11.8 %) of concomitant pathology in children with SVT.

Safety Issues in the Treatment of Paediatric Supraventricular Tachycardias

Drug Safety ◽  
1998 ◽  
Vol 18 (5) ◽  
pp. 345-356 ◽  
Author(s):  
Pierre Pfammatter ◽  
Urs Bauersfeld
Keyword(s):  
Safety Issues ◽  
Supraventricular Tachycardias

Amiodarone for Refractory Supraventricular Tachycardias

2009 ◽  
Vol 221 (5) ◽  
pp. 435-439 ◽  
Author(s):  
K. EMMERTSEN ◽  
P. BJERREGAARD ◽  
F. ANDREASEN
Keyword(s):  
Supraventricular Tachycardias

A novel nonfluoroscopic catheter visualization system (LocaLisa) to reduce radiation exposure during catheter ablation of supraventricular tachycardias

2002 ◽  
Vol 90 (3) ◽  
pp. 340-343 ◽  
Author(s):  
Paulus Kirchhof ◽  
Peter Loh ◽  
Lars Eckardt ◽  
Michael Ribbing ◽  
Sascha Rolf ◽  
...  
Keyword(s):  
Catheter Ablation ◽  
Radiation Exposure ◽  
Visualization System ◽  
Reduce Radiation Exposure ◽  
Supraventricular Tachycardias

Surgery for Atrial Fibrillation and Other Supraventricular Tachycardias

2018 ◽  
pp. 1295-1306
Author(s):  
Matthew R. Schill ◽  
Spencer J. Melby ◽  
Richard B. Schuessler ◽  
Ralph J. Damiano
Keyword(s):  
Atrial Fibrillation ◽  
Supraventricular Tachycardias

scholarly journals Association of rs556621 Polymorphism with Development of Stroke in Patients with Cardiovascular Pathology

2019 ◽  
Vol 15 (5) ◽  
pp. 634-640
Author(s):  
S. Yu. Nikulina ◽  
V. A. Shulman ◽  
A. A. Chernova ◽  
S. V. Prokopenko ◽  
D. A. Nikulin ◽  
...  
Keyword(s):  
Single Nucleotide Polymorphism ◽  
Arterial Hypertension ◽  
Main Group ◽  
Lipid Lowering ◽  
Control Group ◽  
Nucleotide Polymorphism ◽  
Single Nucleotide ◽  
Cardiovascular Pathology ◽  
Supraventricular Tachycardias ◽  
Brachiocephalic Arteries

Aim. To study the association of single nucleotide polymorphism rs556621 (G> T) with development of stroke in patients of the East Siberian population with cardiovascular pathology and risk factors.Material and methods. The study involved 260 patients (157 men and 103 women) with stroke (mean age 57.0 [51.0-62.0]) and 272 patients (170 men and 102 women) of the control group (mean age 55.0 [51.0-62.0]). The examination of the main group included: collection of complaints, anamnesis, clinical examination, computed tomography of the brain, electrocardiography, echocardioscopy, ultrasound duplex scanning of extracranial brachiocephalic arteries, daily blood pressure and heart rate monitoring, analysis of the blood coagulation system. The patients of the main group have arterial hypertension, paroxysmal supraventricular tachycardias, dyslipidemia, atherosclerosis of the brachiocephalic arteries, disorders of the hemostatic system. The control group was studied in the framework of the HAPIEE international project. Molecular genetic research was performed by real-time polymerase chain reaction.Results. There were no statistically significant differences in the frequencies of genotypes and single nucleotide polymorphism rs556621 alleles (G>T) in the subgroup of patients with stroke and those in the control group. The frequency of the rare TT genotype among patients with stroke was 13.3%±4.16, among healthy individuals – 8.8±3.37% (p=0.1). Gender differences when comparing the frequencies of genotypes and alleles were also not detected (p>0.05). The frequencies of the TT genotype were approximately the same in the subgroup of patients with arterial hypertension (13.1%±4.22) and in the control group (7.4±5.25%; p>0.05). No significant differences were observed in the frequencies of the rare genotype of the studied polymorphism in the subgroup of patients with supraventricular tachycardias (20.0±14.37%), hypercoagulability (15.9±7.64%) and the control group (8.8±3.37%), p>0.05. A statistically significant relationship was found between the rare genotype TT of single nucleotide polymorphism rs556621 (G>T) and the development of stroke in patients with dyslipidemia and atherosclerotic lesions of the coronary arteries (p=0.041; odds ratio 1.86, 95% confidence interval 1.02-3.41).Conclusion. The genotype of TTs of single nucleotide polymorphism rs556621 (G> T) increases the risk of developing stroke in patients with dyslipidemia and atherosclerosis of the brachiocephalic arteries compared with carriers of the GG and GT genotypes. The obtained data are recommended to be considered when prescribing lipid-lowering and antithrombotic therapy. 

Adenosine has potential in paediatric supraventricular tachycardias

InPharma ◽  
1989 ◽  
Vol 705 (1) ◽  
pp. 11-11
Keyword(s):  
Supraventricular Tachycardias
Sign in / Sign up

Export Citation Format

Share Document